These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16470482)

  • 1. The launch of the Renin Academy.
    Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):49. PubMed ID: 16470482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The renin-angiotensin system].
    Hilgers KF
    Urologe A; 2009 Aug; 48(8):925-33; quiz 934-5. PubMed ID: 19669119
    [No Abstract]   [Full Text] [Related]  

  • 6. Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2006 Apr; 41(4):451-8. PubMed ID: 16635914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin-aldosterone system and progression of renal disease.
    Rüster C; Wolf G
    J Am Soc Nephrol; 2006 Nov; 17(11):2985-91. PubMed ID: 17035613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
    Usalan C; Buyukhatipoglu H
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.
    Garcia-Donaire JA; Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):56-8. PubMed ID: 17083074
    [No Abstract]   [Full Text] [Related]  

  • 10. Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors.
    Estacio RO
    Postgrad Med; 2009 May; 121(3):33-44. PubMed ID: 19491538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spotlight on renin: intrarenal renin-angiotensin system--important player of the local milieu.
    Haller H; Park JK; Lindschau C; Meyer M; Menne J;
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):122-5. PubMed ID: 17083066
    [No Abstract]   [Full Text] [Related]  

  • 12. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin Academy hosts Topical Workshop session at ESH 2006.
    Renin Academy
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):126-8. PubMed ID: 17083067
    [No Abstract]   [Full Text] [Related]  

  • 14. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel-1364A/C aquaporin 5 gene promoter polymorphism influences the responses to salt loading of the renin-angiotensin-aldosterone system and of blood pressure in young healthy men.
    Adamzik M; Frey UH; Bitzer K; Jakob H; Baba HA; Schmieder RE; Schneider MP; Heusch G; Peters J; Siffert W
    Basic Res Cardiol; 2008 Nov; 103(6):598-610. PubMed ID: 18846354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic inhibition of the renin angiotensin aldosterone system.
    Laight DW
    Expert Opin Ther Pat; 2009 Jun; 19(6):753-9. PubMed ID: 19456280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
    Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A
    J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?
    Lim S
    Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.